Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04529980 · ClinicalTrials.gov registry record · NA
Probiotics and Antibiotic Associated Diarrhea in Pediatric Complicated Appendicitis
A NA study of Appendicitis and Appendicitis; Perforation, sponsored by Children's Health.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT04529980: Completed NA study of Appendicitis and Appendicitis; Perforation, sponsored by Children's Health.
NCT04529980 is a NA study of Appendicitis and Appendicitis; Perforation that has completed, run by Children's Health. The registered enrollment target is 98 participants, below the 2,937-participant average among 8 other Appendicitis trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04529980, a NA study of Appendicitis and Appendicitis; Perforation, has completed, sponsored by Children's Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the effectiveness of the use of probiotics in patients with a diagnosis of complicated appendicitis on antibiotic associated diarrhea (AAD). Probiotics are defined as live microbial organisms that when administered in sufficient amounts, can provide a protective benefit to the individual patient. The use of probiotics in a pediatric population exposed to antibiotics and gastrointestinal surgery such as an appendectomy may provide a protective effect and prevent antibiotic associated diarrhea (ADD)
Primary Outcome
Length of hospital stay measured in hours from admission to discharge. from admission to discharge, up to 1 month
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Lactobacillus rhamnosus GG (LGG) Probiotic
Study Locations (1)
Texas
- Children's Health Children's Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2020-09-08 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
What the finished NCT04529980 record still lists
NCT04529980 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 2,937-participant average among 8 other Appendicitis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Appendicitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04529980 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04529980 about?
NCT04529980 is a clinical study titled "Probiotics and Antibiotic Associated Diarrhea in Pediatric Complicated Appendicitis". To determine the effectiveness of the use of probiotics in patients with a diagnosis of complicated appendicitis on antibiotic associated diarrhea (AAD). Probiotics are defined as live microbial organisms that when administered in sufficient amounts, can provide a protective benefit to the individua...
What is the current status of trial NCT04529980?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2020-09-08. Estimated completion is 2022-02-28.
What conditions does trial NCT04529980 study?
This clinical trial studies the following conditions: Appendicitis, Appendicitis; Perforation.
What interventions are being tested in trial NCT04529980?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Lactobacillus rhamnosus GG (LGG) Probiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04529980?
This trial is sponsored by Children's Health, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04529980 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Appendicitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04529980's enrollment target sits among peer trials
98 7th of 8 higher than 2 of 8 other Appendicitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Appendicitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Operative Versus Non-Operative Management for Appendicitis With Abscess or Phlegmon
RECRUITING · NA
-
Complex and Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX)
RECRUITING · NA
-
PAINED: Project Addressing INequities in the Emergency Department
RECRUITING · NA
-
Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients
RECRUITING · NA
-
Single Incision Laparoscopy
COMPLETED · NA
-
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI